Big pharmaceutical companies and small biotechs alike have jumped into the race to develop treatments and vaccines for the novel coronavirus disease COVID-19. Pfizer (NYSE: PFE) ranks as one of the biggest of the big pharma companies and has several COVID-19 efforts under way. Moderna (NASDAQ: MRNA) stands as a leader among the small biotechs scrambling to develop a coronavirus vaccine.
Moderna has been the undisputed winner between these two stocks so far in 2020. But which of these coronavirus-focused stocks is the better pick for long-term investors?
Image source: Getty Images.